2019
Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus
Njei B, Esserman D, Krishnan S, Ohl M, Tate JP, Hauser RG, Taddei T, Lim J, Justice AC. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus. Medical Care 2019, 57: 279-285. PMID: 30807449, PMCID: PMC6436819, DOI: 10.1097/mlr.0000000000001071.Peer-Reviewed Original ResearchConceptsDirect-acting antiviral agentsHepatitis C virus infectionVeterans Affairs Healthcare SystemRural-Urban Commuting Area codesCurative HCV treatmentRural-urban designationC virus infectionElectronic health record dataHepatitis C virusPrior treatment experienceLower odds ratioHealth record dataZone improvement plan codeEligible patientsHCV treatmentAntiretroviral medicationsRural-urban residenceLiver diseaseUnadjusted analysesC virusRural-urban differencesOdds ratioMultivariable modelLower incidenceObservational study
2018
Palliative care in decompensated cirrhosis: A review
Langberg KM, Kapo JM, Taddei TH. Palliative care in decompensated cirrhosis: A review. Liver International 2018, 38: 768-775. PMID: 29112338, DOI: 10.1111/liv.13620.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPalliative carePatient populationProspective randomized control trialIncidence of cirrhosisPalliative care consultationAdvanced care planningPatient-reported outcomesSmall observational studiesPotential treatment optionCost of careRandomized control trialQuality of lifeLiver transplantSymptom controlICU utilizationLiver diseaseCare consultationsTreatment optionsPatient satisfactionHospital costsObservational studyCirrhosisCare planningControl trialOnly cure
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply